by Clinical Neuropsychologist Online | Tuesday, July 9, 2024 | Neuroscience
Objectives: To assess clinicians’ adherence to fingolimod’s effective use according to the prescribed recommendations to reduce safety risk, identify the consequences, and highlight areas for improvement to policy makers for the benefit of both patient and care-giver....
by Clinical Neuropsychologist Online | Tuesday, July 9, 2024 | Neuroscience
Objectives: To investigate the clinical and genetic features in a cohort of Chinese families with neurofibromatosis type 1 (NF1). Methods: The clinical information of 21 patients with NF1 in 10 families was retrospectively analyzed. To broaden the genetic spectrum of...
by Clinical Neuropsychologist Online | Tuesday, July 9, 2024 | Neuroscience
Objectives: To elucidate the relationship between DNA methylation profiling (DMP) and pathological diagnosis (PD) in pediatric glial and glioneuronal tumors with B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations, addressing their diagnostic challenges....
by Clinical Neuropsychologist Online | Tuesday, July 9, 2024 | Neuroscience
Objectives: To assess the optic disc parameters in healthy Saudi children. Methods: This study recruited 85 children who were medically free, born full-term, cooperative, and aged 3–17 years. The children underwent a thorough ophthalmological examination (visual...
by Clinical Neuropsychologist Online | Tuesday, July 9, 2024 | Neuroscience
Tumefactive demyelinating lesion is a variant of multiple sclerosis that is a diagnostic challenge. Tumefactive demyelinating lesion requires extensive work-up as its clinical and radiological features are often indistinguishable from other central nervous system...
